Clinical trial · Interventional
Optical Surface Guidance for External Radiotherapy of Head and Neck Cancer
Feasibility of Surface Optical Guidance to Replace the Restraint Mask for External Radiotherapy of Head and Neck Cancer
NCT06627075CI-TRIAL-00121876SUGARcompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this clinical trial is to test the use of surface repositioning alone, without a restraint mask, during radiotherapy sessions for patients with head and neck cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Otorhinolaryngeal Cancer | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Surface Guided RadioTherapy (SGRT) without mask | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Surface Guided RadioTherapy without face mask
- description
- Radiotherapy sessions will be carried out using the surface camera system, replacing the restraint mask. Self-assessment questionnaires will also be completed by healthcare professionals concerning the level of difficulty encountered during each SGRT session without mask. Skin side effects are recorded by the radiotherapist during weekly follow-up consultations. At the end of treatment, patients complete a patient experience questionnaire.
- interventionNames
- Procedure: Surface Guided RadioTherapy (SGRT) without mask
Primary outcomes (1)
- measure
- Measurement patient displacement during surface-guided radiotherapy sessions
- timeFrame
- Through study completion, an average of 1 year
- description
- Average length of linear translation vector during session (measured by surface cameras) over all sessions performed
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients over 18 years of age * Patients undergoing palliative or curative treatment for oro-rhino-laryngeal cancer * Patients with an indication for radiotherapy treatment, with or without complementary treatment (chemotherapy, immunotherapy), with a number of sessions between 10 and 35 * Patients who have dated and signed an informed consent form Exclusion Criteria: * Patients with uncontrollable movements * Patients under psychiatric care * Patients who do not understand or read French * Patients participating in an interventional study testing another medical intervention * Patients under guardianship, curatorship, safeguard of justice or deprived of liberty * Pregnant or breast-feeding women * Patients without social security coverage
References
Publications (0)
Data not yet available
No reference posted for this study.